LARIMAR THERAPEUTICS, INC. Operating Lease, Expense
LARIMAR THERAPEUTICS, INC. (LRMR) reported Operating Lease, Expense of $200.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-08-04
- LARIMAR THERAPEUTICS, INC. operating lease, expense for the quarter ending 2026-06-30 was $200.00K, a 100.00% increase year-over-year.
- LARIMAR THERAPEUTICS, INC. operating lease, expense for the quarter ending 2026-03-31 was $100.00K, a 0.00% change year-over-year.
- LARIMAR THERAPEUTICS, INC. operating lease, expense for the quarter ending 2025-12-31 was $200.00K, a 100.00% increase year-over-year.
- LARIMAR THERAPEUTICS, INC. operating lease, expense for the quarter ending 2025-09-30 was $100.00K, a 0.00% change year-over-year.
- LARIMAR THERAPEUTICS, INC. operating lease, expense for fiscal 2025 was $600.00K, a 20.00% increase from fiscal 2024.
- LARIMAR THERAPEUTICS, INC. operating lease, expense for fiscal 2024 was $500.00K, a 25.00% increase from fiscal 2023.
- LARIMAR THERAPEUTICS, INC. operating lease, expense for fiscal 2023 was $400.00K, a 33.33% increase from fiscal 2022.
- LARIMAR THERAPEUTICS, INC. operating lease, expense for fiscal 2022 was $300.00K, a 0.00% change from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $200.00K 10-Q · filed 2026-08-04 | $300.00K 10-Q · filed 2026-08-04 | $500.00K derived: sum of 3 quarters · filed 2026-08-04 | $600.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-14 | $300.00K derived: sum of 2 quarters · filed 2026-05-14 | $400.00K derived: sum of 3 quarters · filed 2026-05-14 | $500.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $300.00K derived: sum of 2 quarters · filed 2026-03-19 | $400.00K derived: sum of 3 quarters · filed 2026-08-04 | $600.00K 10-K · filed 2026-03-19 |
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-05 | $200.00K derived: sum of 2 quarters · filed 2026-08-04 | $400.00K 10-Q · filed 2025-11-05 | $400.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $100.00K 10-Q · filed 2026-08-04 | $300.00K 10-Q · filed 2026-08-04 | $300.00K derived: sum of 3 quarters · filed 2026-08-04 | $400.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $100.00K 10-Q · filed 2026-05-14 | $200.00K derived: sum of 2 quarters · filed 2026-05-14 | $300.00K derived: sum of 3 quarters · filed 2026-05-14 | $400.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $200.00K derived: sum of 2 quarters · filed 2026-03-19 | $300.00K derived: sum of 3 quarters · filed 2026-03-19 | $500.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | $100.00K 10-Q · filed 2025-11-05 | $200.00K derived: sum of 2 quarters · filed 2025-11-05 | $400.00K 10-Q · filed 2025-11-05 | $500.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $100.00K 10-Q · filed 2025-08-14 | $300.00K 10-Q · filed 2025-08-14 | $400.00K derived: sum of 3 quarters · filed 2025-08-14 | $500.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $100.00K 10-Q · filed 2025-04-30 | $300.00K derived: sum of 2 quarters · filed 2025-04-30 | $400.00K derived: sum of 3 quarters · filed 2025-04-30 | $500.00K derived: sum of 4 quarters · filed 2025-04-30 |
| 2023-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $300.00K derived: sum of 2 quarters · filed 2025-03-24 | $400.00K derived: sum of 3 quarters · filed 2025-03-24 | $400.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | $100.00K 10-Q · filed 2024-10-30 | $200.00K derived: sum of 2 quarters · filed 2024-10-30 | $200.00K 10-Q · filed 2024-10-30 | $400.00K derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-06-30 | $100.00K 10-Q · filed 2024-08-08 | $200.00K 10-Q · filed 2024-08-08 | $300.00K derived: sum of 3 quarters · filed 2024-08-08 | $400.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $100.00K 10-Q · filed 2024-05-09 | $200.00K derived: sum of 2 quarters · filed 2024-05-09 | $300.00K derived: sum of 3 quarters · filed 2024-05-09 | $400.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $200.00K derived: sum of 2 quarters · filed 2024-03-14 | $300.00K derived: sum of 3 quarters · filed 2024-03-14 | $300.00K 10-K · filed 2024-03-14 |
| 2022-09-30 | $100.00K 10-Q · filed 2023-11-14 | $200.00K derived: sum of 2 quarters · filed 2023-11-14 | $200.00K 10-Q · filed 2023-11-14 | $400.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $100.00K 10-Q · filed 2023-08-10 | $200.00K 10-Q · filed 2023-08-10 | $300.00K derived: sum of 3 quarters · filed 2023-08-10 | $400.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $100.00K 10-Q · filed 2023-05-15 | $200.00K derived: sum of 2 quarters · filed 2023-05-15 | $300.00K derived: sum of 3 quarters · filed 2023-05-15 | $400.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $200.00K derived: sum of 2 quarters · filed 2023-03-14 | $300.00K derived: sum of 3 quarters · filed 2023-03-14 | $300.00K 10-K · filed 2023-03-14 |
| 2021-09-30 | $100.00K 10-Q · filed 2022-11-10 | $200.00K derived: sum of 2 quarters · filed 2022-11-10 | $200.00K 10-Q · filed 2022-11-10 | $600.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $100.00K 10-Q · filed 2022-08-11 | $100.00K 10-Q · filed 2022-08-11 | $500.00K derived: sum of 3 quarters · filed 2022-08-11 | $800.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $100.00K 10-Q · filed 2022-05-12 | $400.00K derived: sum of 2 quarters · filed 2022-05-12 | $700.00K derived: sum of 3 quarters · filed 2022-05-12 | $800.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $600.00K derived: sum of 2 quarters · filed 2022-03-25 | $700.00K derived: sum of 3 quarters · filed 2022-03-25 | $700.00K 10-K · filed 2022-03-25 |
| 2020-09-30 | $300.00K 10-Q · filed 2021-11-12 | $400.00K derived: sum of 2 quarters · filed 2021-11-12 | $400.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $100.00K 10-Q · filed 2021-08-12 | $100.00K 10-Q · filed 2021-08-12 | ||
| 2018-06-30 | $100.00K 10-Q · filed 2019-08-08 | $200.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $100.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |